Qiagen
Rockefeller Foundation Funds Global Pathogen Sequencing With $20M, Forms Collaborations
The funding and alliances mark the first step in the foundation's establishment of a pandemic prevention institute, which will collaborate with similar efforts elsewhere.
Illumina, Qiagen, Columbia University Near Settlement in Patent Infringement Case
It is unclear whether the impending settlement will affect all the litigation between the two sides, across several legal venues.
FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen
The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC.
Qiagen Q1 Revenues Jump 52 Percent
The company beat analysts'Â estimates and exceeded previously provided guidance for revenue growth and EPS, driven by non-COVID-19-related product sales.